Lozaska Tablet 5/100 mg
Losartan Potassium 100mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Biochem Pharmaceuticals Co., Ltd.
MFDS item code 201504976 · Approved 2015.07.21
This product's status changed to Approval withdrawn on 2025.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Essential hypertension uncontrolled with monotherapy; initial treatment of stage 2 hypertension
This medication is used in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy using amlodipine or losartan. Additionally, it is utilized as an initial therapy in patients with stage 2 hypertension who require combination therapy to reach target blood pressure. Therefore, this drug is effectively used for hypertension management and blood pressure control.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before administering this medicine; however, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. - 5/50 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams monotherapy. - 5/100 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with the combination product compared with the individual components. The usual dose is 5/50 milligrams once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: Dose adjustment is not necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients on dialysis. ○ Patients with reduced intravascular effective circulating volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular effective circulating volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Older adults: In older adults aged 75 years and older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years and younger; therefore, its use is not recommended.
This medication can cause serious harm or death to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Taking this medication during pregnancy can increase the risk of impaired fetal kidney function, oligohydramnios, growth retardation, and other congenital anomalies. Patients with low blood volume or those on diuretics should stabilize their condition before taking this medication, as hypotension may occur. Individuals with hypersensitivity to any of the ingredients in this medication, pregnant women, breastfeeding mothers, patients with severe liver dysfunction, severe aortic stenosis, and those in a state of shock should not take this medication. Patients with low blood volume or impaired kidney function, those requiring strict salt restriction, and patients with hyperkalemia should be monitored closely when taking this medication. This medication may occasionally cause side effects like dizziness, headache, indigestion, skin rash, palpitations along with neurological abnormalities such as dizziness or headache. If symptoms like sudden severe hypotension, loss of consciousness, or difficulty breathing arise, discontinue use immediately and consult a healthcare professional. The effect may be enhanced if this medication is taken with other antihypertensives, so it should be taken as directed by a healthcare professional. Avoid taking with grapefruit juice as it may increase drug concentration. Absolutely avoid use during pregnancy and be cautious during breastfeeding as this medication can be excreted in breast milk. Use is not recommended for children under 18 years of age as its safety and efficacy have not been established. For elderly patients, especially those over 75 years of age, initial dosage adjustment is required, so consultation with a healthcare professional is advised. In case of overdose, severe hypotension and cardiac arrhythmias may occur, requiring immediate emergency treatment and it is not removed through dialysis. Store this medication out of reach of children, and it is safer not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is recommended to maintain storage temperature in the range of 1 to 30 degrees Celsius at room temperature.
White oblong film-coated tablet
For domestic use - 30 tablets/bottle, for export - 30 tablets/PTP [(10 tablets/PTP*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium 100mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Biochem Pharmaceuticals Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Huwons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.